US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.330
  • +0.130+2.10%
Close Feb 28 16:00 ET
  • 6.330
  • 0.0000.00%
Post 17:34 ET
562.08MMarket Cap-2.69P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.45%-157.69M
-0.41%-40.85M
-235.34%-39.61M
28.78%-34.16M
12.25%-43.08M
-22.25%-149.55M
-23.68%-40.68M
59.52%-11.81M
-79.24%-47.96M
-46.52%-49.1M
Net income from continuing operations
0.68%-198.71M
-3.48%-50.04M
-9.56%-50.13M
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
Depreciation and amortization
23.79%6.75M
12.06%1.7M
19.00%1.75M
24.68%1.67M
44.81%1.63M
94.54%5.46M
64.00%1.52M
105.58%1.47M
106.33%1.34M
119.26%1.13M
Other non cash items
-14.37%5.68M
-16.88%2.04M
97.29%1.82M
-94.90%120K
89.04%1.69M
173.73%6.63M
547.91%2.46M
-79.87%923K
636.76%2.35M
175.89%894K
Change In working capital
-112.77%-2.26M
-28.29%-2.85M
-104.28%-1.12M
292.73%5.75M
-22.08%-4.04M
111.25%17.7M
-168.22%-2.22M
434.08%26.22M
-138.12%-2.98M
56.49%-3.31M
-Change in receivables
144.77%2.64M
77.44%-626K
120.14%410K
208.09%2.69M
-88.03%168K
-482.21%-5.89M
-3,243.37%-2.78M
---2.04M
---2.49M
--1.4M
-Change in prepaid assets
-475.04%-8.09M
-211.77%-1.32M
-155.12%-1.82M
-992.28%-4.27M
71.44%-672K
85.10%-1.41M
1,836.76%1.18M
88.99%-713K
111.85%479K
-304.79%-2.35M
-Change in payables and accrued expense
-23.97%2.8M
132.00%2.95M
-120.94%-311K
313.49%7.11M
-771.55%-6.96M
101.59%3.68M
-64.42%1.27M
125.13%1.49M
-86.12%1.72M
90.31%-798K
-Change in other current liabilities
31.79%-4.93M
33.05%-1.27M
-15.41%-1.22M
55.60%-1.2M
21.10%-1.23M
-139.79%-7.22M
-1,017.65%-1.9M
40.99%-1.06M
-413.90%-2.7M
-199.04%-1.56M
-Change in other working capital
-81.38%5.31M
-129,150.00%-2.58M
--1.82M
--1.43M
--4.65M
42.61%28.54M
--2K
----
----
----
Cash from discontinued investing activities
Operating cash flow
-5.45%-157.69M
-0.41%-40.85M
-235.34%-39.61M
28.78%-34.16M
12.25%-43.08M
-22.25%-149.55M
-23.68%-40.68M
59.52%-11.81M
-79.24%-47.96M
-46.52%-49.1M
Investing cash flow
Cash flow from continuing investing activities
170.41%74.88M
432.24%29.55M
580.07%56.81M
-8.71%30.15M
-370.48%-41.63M
117.76%27.69M
94.72%-8.89M
78.68%-11.83M
324.38%33.03M
-74.39%15.39M
Net PPE purchase and sale
59.75%-3.74M
36.52%-1.39M
11.78%-936K
63.19%-980K
87.17%-433K
29.84%-9.28M
56.02%-2.19M
59.76%-1.06M
2.10%-2.66M
-16.06%-3.38M
Net investment purchase and sale
112.62%78.61M
561.14%30.93M
636.04%57.75M
-12.77%31.13M
-319.53%-41.2M
125.91%36.97M
95.89%-6.71M
79.63%-10.77M
239.84%35.69M
-70.21%18.77M
Cash from discontinued investing activities
Investing cash flow
170.41%74.88M
432.24%29.55M
580.07%56.81M
-8.71%30.15M
-370.48%-41.63M
117.76%27.69M
94.72%-8.89M
78.68%-11.83M
324.38%33.03M
-74.39%15.39M
Financing cash flow
Cash flow from continuing financing activities
-76.86%49.2M
-85.82%25.15M
-99.96%14K
5.27%1.3M
1,015.51%22.73M
-35.38%212.58M
347.96%177.38M
-88.93%31.92M
177.08%1.23M
303.56%2.04M
Net common stock issuance
-77.79%46.73M
-86.26%24.3M
--0
21.54%-51K
1,031.56%22.48M
-35.54%210.46M
358.21%176.82M
-88.99%31.71M
---65K
--1.99M
Proceeds from stock option exercised by employees
-1.98%2.53M
-10.03%915K
-93.43%14K
5.27%1.3M
159.48%301K
-20.50%2.58M
-14.25%1.02M
-80.78%213K
177.08%1.23M
-77.03%116K
Net other financing activities
85.59%-66K
----
----
----
21.54%-51K
41.51%-458K
----
----
----
---65K
Cash from discontinued financing activities
Financing cash flow
-76.86%49.2M
-85.82%25.15M
-99.96%14K
5.27%1.3M
1,015.51%22.73M
-35.38%212.58M
347.96%177.38M
-88.93%31.92M
177.08%1.23M
303.56%2.04M
Net cash flow
Beginning cash position
75.45%210.95M
96.63%163.48M
95.37%146.26M
68.20%148.97M
75.45%210.95M
72.83%120.24M
-70.50%83.14M
-4.17%74.87M
-8.37%88.57M
72.83%120.24M
Current changes in cash
-137.06%-33.62M
-89.16%13.85M
108.01%17.22M
80.22%-2.71M
-95.73%-61.98M
79.04%90.72M
179.09%127.81M
-95.94%8.28M
26.05%-13.7M
-216.89%-31.67M
End cash Position
-15.94%177.33M
-15.94%177.33M
96.63%163.48M
95.37%146.26M
68.20%148.97M
75.45%210.95M
75.45%210.95M
-70.50%83.14M
-4.17%74.87M
-8.37%88.57M
Free cash flow
-1.63%-161.43M
1.48%-42.23M
-214.97%-40.54M
30.59%-35.14M
17.07%-43.52M
-17.16%-158.83M
-13.22%-42.87M
59.54%-12.87M
-71.74%-50.62M
-44.09%-52.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.45%-157.69M-0.41%-40.85M-235.34%-39.61M28.78%-34.16M12.25%-43.08M-22.25%-149.55M-23.68%-40.68M59.52%-11.81M-79.24%-47.96M-46.52%-49.1M
Net income from continuing operations 0.68%-198.71M-3.48%-50.04M-9.56%-50.13M7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M
Depreciation and amortization 23.79%6.75M12.06%1.7M19.00%1.75M24.68%1.67M44.81%1.63M94.54%5.46M64.00%1.52M105.58%1.47M106.33%1.34M119.26%1.13M
Other non cash items -14.37%5.68M-16.88%2.04M97.29%1.82M-94.90%120K89.04%1.69M173.73%6.63M547.91%2.46M-79.87%923K636.76%2.35M175.89%894K
Change In working capital -112.77%-2.26M-28.29%-2.85M-104.28%-1.12M292.73%5.75M-22.08%-4.04M111.25%17.7M-168.22%-2.22M434.08%26.22M-138.12%-2.98M56.49%-3.31M
-Change in receivables 144.77%2.64M77.44%-626K120.14%410K208.09%2.69M-88.03%168K-482.21%-5.89M-3,243.37%-2.78M---2.04M---2.49M--1.4M
-Change in prepaid assets -475.04%-8.09M-211.77%-1.32M-155.12%-1.82M-992.28%-4.27M71.44%-672K85.10%-1.41M1,836.76%1.18M88.99%-713K111.85%479K-304.79%-2.35M
-Change in payables and accrued expense -23.97%2.8M132.00%2.95M-120.94%-311K313.49%7.11M-771.55%-6.96M101.59%3.68M-64.42%1.27M125.13%1.49M-86.12%1.72M90.31%-798K
-Change in other current liabilities 31.79%-4.93M33.05%-1.27M-15.41%-1.22M55.60%-1.2M21.10%-1.23M-139.79%-7.22M-1,017.65%-1.9M40.99%-1.06M-413.90%-2.7M-199.04%-1.56M
-Change in other working capital -81.38%5.31M-129,150.00%-2.58M--1.82M--1.43M--4.65M42.61%28.54M--2K------------
Cash from discontinued investing activities
Operating cash flow -5.45%-157.69M-0.41%-40.85M-235.34%-39.61M28.78%-34.16M12.25%-43.08M-22.25%-149.55M-23.68%-40.68M59.52%-11.81M-79.24%-47.96M-46.52%-49.1M
Investing cash flow
Cash flow from continuing investing activities 170.41%74.88M432.24%29.55M580.07%56.81M-8.71%30.15M-370.48%-41.63M117.76%27.69M94.72%-8.89M78.68%-11.83M324.38%33.03M-74.39%15.39M
Net PPE purchase and sale 59.75%-3.74M36.52%-1.39M11.78%-936K63.19%-980K87.17%-433K29.84%-9.28M56.02%-2.19M59.76%-1.06M2.10%-2.66M-16.06%-3.38M
Net investment purchase and sale 112.62%78.61M561.14%30.93M636.04%57.75M-12.77%31.13M-319.53%-41.2M125.91%36.97M95.89%-6.71M79.63%-10.77M239.84%35.69M-70.21%18.77M
Cash from discontinued investing activities
Investing cash flow 170.41%74.88M432.24%29.55M580.07%56.81M-8.71%30.15M-370.48%-41.63M117.76%27.69M94.72%-8.89M78.68%-11.83M324.38%33.03M-74.39%15.39M
Financing cash flow
Cash flow from continuing financing activities -76.86%49.2M-85.82%25.15M-99.96%14K5.27%1.3M1,015.51%22.73M-35.38%212.58M347.96%177.38M-88.93%31.92M177.08%1.23M303.56%2.04M
Net common stock issuance -77.79%46.73M-86.26%24.3M--021.54%-51K1,031.56%22.48M-35.54%210.46M358.21%176.82M-88.99%31.71M---65K--1.99M
Proceeds from stock option exercised by employees -1.98%2.53M-10.03%915K-93.43%14K5.27%1.3M159.48%301K-20.50%2.58M-14.25%1.02M-80.78%213K177.08%1.23M-77.03%116K
Net other financing activities 85.59%-66K------------21.54%-51K41.51%-458K---------------65K
Cash from discontinued financing activities
Financing cash flow -76.86%49.2M-85.82%25.15M-99.96%14K5.27%1.3M1,015.51%22.73M-35.38%212.58M347.96%177.38M-88.93%31.92M177.08%1.23M303.56%2.04M
Net cash flow
Beginning cash position 75.45%210.95M96.63%163.48M95.37%146.26M68.20%148.97M75.45%210.95M72.83%120.24M-70.50%83.14M-4.17%74.87M-8.37%88.57M72.83%120.24M
Current changes in cash -137.06%-33.62M-89.16%13.85M108.01%17.22M80.22%-2.71M-95.73%-61.98M79.04%90.72M179.09%127.81M-95.94%8.28M26.05%-13.7M-216.89%-31.67M
End cash Position -15.94%177.33M-15.94%177.33M96.63%163.48M95.37%146.26M68.20%148.97M75.45%210.95M75.45%210.95M-70.50%83.14M-4.17%74.87M-8.37%88.57M
Free cash flow -1.63%-161.43M1.48%-42.23M-214.97%-40.54M30.59%-35.14M17.07%-43.52M-17.16%-158.83M-13.22%-42.87M59.54%-12.87M-71.74%-50.62M-44.09%-52.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!